Impact of AR-V7 protein localization in the prediction of therapeutic benefit of taxanes over androgen receptor signaling inhibitors (ARSi) in metastatic castration resistant prostate cancer (mCRPC)

Authors :: Ryon P. Graf
David S.K. Lu
H.A. Vargas Alvarez
Nicole A. Schreiber
Howard I. Scher
G. Heller
Brigit McLaughlin
Daniel C. Danila
Richard Martin Bambury
Jessica Louw
Martin Fleisher
Ryan Dittamore
Source :: Annals of Oncology. 27:vi248
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
Androgen receptor
Prostate cancer
medicine.medical_specialty
business.industry
Internal medicine
Medicine
Hematology
Castration resistant
business
medicine.disease
Protein subcellular localization prediction

Full Text Access

Tools